Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
about
CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritisInhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3Properdin: a tightly regulated critical inflammatory modulatorTolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cellsBlockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody.The alphaMbeta2 integrin and its role in neutrophil function.CD40L and Its Receptors in Atherothrombosis-An UpdateNeutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3Yersinia pestis targets neutrophils via complement receptor 3Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.Role of the terminal complement pathway in accelerated autologous anti-glomerular basement membrane nephritis.Molecular basis for complement recognition by integrin αXβ2.Complement-mediated binding of monocytes to intermediate filaments in vitro.Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria.CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiationIdentification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Anti-Mac-1 selectively inhibits the mouse and human type three complement receptorGeneration of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3Epstein-Barr virus regulates activation and processing of the third component of complement.Ultrastructure and composition of bovine conglutinin.Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activityOpsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptorsIdentification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria.C3d receptors are expressed on human monocytes after in vitro cultivationThe role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse.A discrete site modulates activation of I domains. Application to integrin alphaMbeta2.Cross-linking of at least three binding sites mediates signal transduction in a CR2-positive Burkitt lymphoma derived cell line (Raji).Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1.Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix.Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.A possible self-regulating mechanism mediated by C3b-acceptor-bound C3b generated by stimulated macrophages.Delineation of the key amino acids involved in neutrophil inhibitory factor binding to the I-domain supports a mosaic model for the capacity of integrin alphaMbeta 2 to recognize multiple ligands.A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers.
P2860
Q21285053-64EA867B-5CD7-4433-84A2-60F97187DC17Q24527312-5F6B9759-BEA9-4BF7-8DEF-486A7945868BQ27680051-E1AA8F35-C80E-475E-BFF2-7F233048CF5DQ28069187-32D75114-9A42-41A9-BE99-A4F5BAA34D32Q28565650-1F0D793B-420E-4BE5-BE2F-3316A52B09ECQ30442750-BC74DA49-397F-4B62-AD8A-0956E4C83628Q33751497-1FDBB8FD-AB52-4087-8715-5FC98EE59112Q33814059-3A2BAFFF-3B83-437A-B54D-61153281B769Q34560294-5D6F0368-9667-4EF4-BD19-BE16A8952F16Q35470536-D06BB416-0C86-4427-9D24-ADE32B6F1D84Q35795164-5FA6EA44-F37A-4950-8180-BCE37F4396B9Q35811430-46D8AFC9-BA5A-45DE-903C-E17CDECBFDD7Q35849584-8AB93E55-E525-42DA-99EB-79A6F91DB5A8Q35886025-02809EA1-35BA-47D4-8A71-3BDD474A04D6Q35953532-B865AF83-EE71-44B9-8586-698BADEBEAF4Q36229469-52571F08-63B3-44F5-9EAB-0844C6B26D60Q36254495-5A76E585-5039-44F7-BEE6-68B40CB15AF5Q36273277-9CD16D12-BBF6-4560-B5A3-C924F13520ADQ36347029-9ADE63FC-5068-4DB8-918C-C205E058F326Q36348883-BDF2C929-A730-440C-88B4-6C2B91A8443BQ36349022-6BF54C5F-BE17-4538-B7B5-0B6305B65458Q36349693-DD0BAAB6-4343-4911-93DC-F24E5242B625Q36350126-0C1968CE-43F1-40D5-A7F2-B01D6E6BF2C9Q36355255-9AA06ACE-4431-48A0-B649-7568264B918AQ36476145-B9173ED3-0EFB-46E1-9B96-CF339C1C3374Q36967011-43276D0C-D319-4081-A33C-3D74355EDDA4Q37032554-206A647A-1D2A-4079-BDA8-2B06BDA0CEE6Q37505380-3042DBCF-6884-4BE1-AFBE-551CC29ABC36Q37609479-5ED4CFCE-5049-4C68-A6F8-729D62C9DA95Q37855061-564BB090-55BB-4E23-B3AA-CB7C8FB89973Q41150359-3F82103F-143F-4E14-B995-81501FBA348FQ41294052-5E51D090-35A7-47AE-9CCA-92872E12E044Q41870678-BA0E5C26-7B6D-40E4-BD88-BB913D1D31FDQ42848411-45C6612C-E6C5-467C-8145-1E2111B475EAQ42848656-9BDA765B-5554-4392-B60A-28EE5E55ADD2Q43279104-BB443F63-EAED-46CD-AFA9-EA366D39C6B3Q43577832-B1B6A4F2-9AA0-4D5A-B4F9-41F2AD7D4E96Q43906929-A40CC544-A44E-40A7-A92E-EA51DE2F55C1Q48095930-B904FAB1-9831-4162-BB74-50128D859A2CQ51758607-DAE6EAA7-9D60-406E-B3C8-5619CE07BDB7
P2860
Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@ast
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@en
type
label
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@ast
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@en
prefLabel
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@ast
Identification of a C3bi-speci ...... neutrophils, and erythrocytes.
@en
P2860
P356
P1476
Identification of a C3bi-speci ...... neutrophils, and erythrocytes
@en
P2093
P2860
P304
P356
10.1084/JEM.155.1.96
P407
P577
1982-01-01T00:00:00Z